Waters Corporation Investor Presentation — January 2022

Document content

January 10, 2022J.P. Morgan 40th Annual Healthcare

Conference2 ©2022 Waters Corporation

This presentation contains forward -looking statements regarding future results and events. For this purpose, any statements that are not statements of

historical fact may be deemed forward -looking statements. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate ,” “intend” , “project” and

similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intend ed to identify forward -looking

statements. Forward -looking statements are based on current expectations and assumptions and currently available data and are ne ither predictions nor

guarantees of future events or performance. You should not place undue reliance on forward -looking statements, which speak only as of the date hereof

and should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this presentation. We do not

undertake to update or revise any forward -looking statements after they are made, whether as a result of new information, future events, or otherwise,

except as required by applicable law. The Company’s actual future results may differ significantly from the results discussed inthe forward -looking

statements within this presentation for a variety of reasons, including and without limitation, risks related to the effects of the ongoing COVID -19 pandemic

on our business, financial condition, results of operations and prospects, including: portions of our global workforce being unable to work fully and/or

effectively due to working remotely, illness, quarantines, government actions, facility closures or other reasons related to thepandemic, increased risks of

cyber -attacks resulting from our temporary remote working model, disruptions in our manufacturing capabilities or to our supply chain, volatility and

uncertainty in global capital markets limiting our ability to access capital, customers being unable to make timely payments forpurchases and volatility in

demand for our products; foreign exchange rate fluctuations potentially affecting translation of the Company’s future non -U.S. o perating results; fluctuations

in expenditures by the Company’s customers, in particular large pharmaceutical companies; environmental and logistical obstac lesaffecting the distribution

of products and risks associated with lawsuits and other legal actions, particularly involving claims for infringement of pat ents and other intellectual property

rights. Such factors and others are discussed more fully in the sections entitled “Forward -Looking Statements” and “Risk Factors ” of the Company’s annual